Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | PARP1 | P09874 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL528834 | 0.91 | MAPT (0.62) | MAPTHTTGAALMNAKDM4E | |
| SCHEMBL527908 | 0.91 | MAPT (0.61) | MAPTHTTGAALMNAKDM4E | |
| SCHEMBL528500 | 0.90 | MAPT (0.77) | MAPTHTTGAALMNAKDM4E | |
| SCHEMBL528264 | 0.90 | MAPT (0.60) | MAPTHTTGAALMNAKDM4E | |
| SCHEMBL529489 | 0.89 | MAPT (0.62) | MAPTHTTGAALMNAKDM4E | |
| SCHEMBL529230 | 0.87 | MAPT (0.49) | MAPTHTTLMNAKDM4EALDH1A1 | |
| SCHEMBL528625 | 0.85 | MAPT (0.54) | MAPTHTTGAALMNAKDM4E | |
| SCHEMBL528224 | 0.84 | ALDH1A1 (0.56) | MAPTHTTGAALMNAKDM4E | |
| SCHEMBL528415 | 0.82 | LMNA (0.57) | MAPTHTTGAALMNAPARP1 | |
| SCHEMBL529256 | 0.81 | MAPT (0.66) | MAPTHTTGAALMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012014127-A1 | 5-LIPOXYGENASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2012-02-02 | — | — | WO | disclosed |